Market Overview

Lightning Round: Jim Cramer Advises His Viewers On Teva, Snap And More

Share:
Related KEM
70 Biggest Movers From Yesterday
54 Stocks Moving In Monday's Mid-Day Session
Related
Analysts Forecast What's Next For Lumentum After The Oclaro Acquisition
21 Stocks Moving In Thursday's Pre-Market Session
Apple suppliers dip on China's iPhone ban (Seeking Alpha)

On CNBC's "Mad Money Lightning Round", Jim Cramer said KEMET Corporation (NYSE: KEM) is a cheap stock. He doesn't have a catalyst, but he likes the stock and he's surprised it's trading this low.

Cramer isn't a buyer of Lumentum Holdings Inc (NASDAQ: LITE). He would rather own Finisar Corporation (NASDAQ: FNSR).

Cramer would stay away from Snap Inc (NYSE: SNAP).

Applied Materials, Inc. (NASDAQ: AMAT) is a good stock, said Cramer.

Instead of Okta Inc (NASDAQ: OKTA), Cramer would rather buy VMware, Inc. (NYSE: VMW).

Cramer wouldn't buy Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA). He doesn't want to touch the stock.

Posted-In: CNBC mad money Lightning Round Jim CramerMedia

 

Related Articles (AMAT + FNSR)

View Comments and Join the Discussion!

ICYMI: T-Mobile Terrorizes Telecom Space, 2017 ASH Recap, Bitcoin Continues To Dominate The News Cycle

Avis, Freeport-McMoRan, Target: 'Fast Money' Picks For December 14